Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Blinded, Active and Placebo-Controlled, Crossover Study of the Efficacy and Safety of Two Doses of Adipiplon Bilayer Tablets in Primary Insomniacs

NCT00683436 is registered in ClinicalTrials.gov with Neurogen Corporation as lead sponsor.

NCT NCT00683436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00683436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Blinded, Active and Placebo-Controlled, Crossover Study of the Efficacy and Safety of Two Doses of Adipiplon Bilayer Tablets in Primary Insomniacs
Lead sponsor
Neurogen Corporation
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2008
Completion date
November 30, 2008
Enrollment
84 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

primary insomnia